AGTC - Applied Genetic Tech to expand study of gene therapy for vision loss disorder July, 22 2020 07:42 AM Applied Genetic Technologies Corporation Based on FDA feedback, Applied Genetic Technologies (NASDAQ:AGTC) has revised the development plan for its gene therapy for X-linked retinitis pigmentosa, an inherited disorder affecting the retina that leads to vision loss.More news on: Applied Genetic Technologies Corporation, Healthcare stocks news, Stocks on the move, Read more ...